Literature DB >> 11436962

Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.

J E Otka, M T Mercadante, L Scahill, J F Leckman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11436962     DOI： 10.1089/104454601750284135

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  3 in total

1.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

2.  A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD).

Authors:  F Hashemian; S Mohammadian; F Riahi; P Ghaeli; D Ghodsi
Journal:  Daru       Date:  2011       Impact factor: 3.117

3.  Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders.

Authors:  Forough Riahi; Ashraf Tashakori; Sakineh Izadi-Mazidi; Mohammad Salehi-Veysi
Journal:  Iran J Psychiatry       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.